Company Profile
CONMED Stock Price, News & Analysis
- Ticker:
- CNMD
- Exchange:
- NYSE
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NYSE, CONMED is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
33.80 USD (+3.87%)
Close
Last updated: June 23, 2026 at 00:00
1.02B USD
Market cap
Why the stock is moving
CNMD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
CONMED is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, CONMED is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
CONMED follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, CONMED sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of CONMED (CNMD)?
CONMED (CNMD) most recently closed at 33.80 USD, a +3.87% move versus the previous session.
What is the market cap of CONMED (CNMD)?
CONMED currently has a market capitalization of 1.02B USD on BioPharmSignal.
What does CONMED do?
CONMED is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is CNMD stock listed?
CONMED (CNMD) is associated with NYSE, Headquartered in the United States and listed on NYSE, CONMED is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Which conditions is CONMED targeting with Investors?
CONMED is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.